Research consortium building scaffolding for Precision Medicine Initiative’s All of Us
Last week, the National Institutes of Health, which is heading the initiative, rebranded the Precision Medicine Initiative's cohort program as "All of Us."
Child prodigy’s approach to diagnosing concussions nabs spot in pediatric medical device contest
Averia, co-founded by Rohan Suri, has developed a way to diagnose concussions which combines an iPhone, an app and a cardboard headset.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Protein-motion startup launches armed with $57M to develop drugs, crack cancer code
Relay Therapeutics is aiming to identify the way proteins in cells move and shift and morph, and this understanding can help open the door to new, more effective drugs.
UPMC backs cancer diagnostics startup Cernostics
Cernostics is part of the wave of oncology that looks at cancer at the tissue and cellular level instead of focusing on the location of the tumor — lung, stomach, pancreas.
Startup Spirometrix readies connected asthma sensors for market
Spirometrix wants to see nearly 20 percent of pulmonologists and allergists using the Fenom Pro sensor by 2020.
Chinese-backed developer gets OK for $1B biotech campus on SF Bay
An initial $300 million injection will set the development in motion and by 2021, the entire 2.25 million square-foot site is expected to be developed.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
AncestryDNA sees huge growth in demand for genetic testing
The demand has been so strong that consumer genetics company, AncestryDNA, now has a database of two million samples.
New partnerships aims to unlock mysteries of traumatic brain injury
Quanterix and Banyan Biomarkers want to study two proteins about which not much is known but that show up in the blood when humans take a blow to their head.
After $371M merger, what comes next for LabCorp and Sequenom?
The two companies are perched on a risky, competitive genetic testing market valued in 2015 at $3 billion.
This telemed app aims to replace the patient visit entirely
SmartExam from Bright.MD is being adopted in places like the Rush University Medical Center to replace in-person routine care with telemedicine so the focus can be on sicker patients.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Health data should belong to patients, Topol argues
What constitutes health data is no longer so easily defined. Neither is how the information is used.
IMS Health: Type 2 diabetes non-adherence costs U.S. $4B
IMS identified five major drivers that impact how well people followed their diabetes care: health beliefs and attitude; personal circumstances; health status; health literacy; and access and affordability.
Bristol Myers’ small deal underscores how hot immuno-oncology is
BMS' purchase of Cormorant shows that no deal is too small when it comes to immuno-oncology.
5 takeaways from Bioventus IPO move
Bioventus develops orthopedic products designed to treat conditions affecting muscles, bones and joints. Its top sellers include a therapy for fractures and osteoarthritis,
Emerge Diagnostics raises fresh capital to detect injuries in workers compensation industry
Emerge Diagnostics entered the tumultuous workers compensation industry four years ago with a device able to detect the kind of workplace injuries that cost employers millions of dollars annually, but are the hardest to spot.